Aprea Therapeutics, Inc. (APRE) — Shares Outstanding
| Fiscal Year | Shares Outstanding | Change YoY |
|---|---|---|
| 2025 | 8.19M | +49.5% |
| 2024 | 5.48M | +46.7% |
| 2023 | 3.74M | +40.7% |
| 2022 | 2.66M | +142.9% |
| 2021 | 1.09M | -94.8% |
| 2020 | 21.19M | +0.8% |
| 2019 | 21.02M | +1719.6% |
| 2018 | 1.16M | — |
| Fiscal Year | Shares Outstanding | Change YoY |
|---|---|---|
| 2025 | 8.19M | +49.5% |
| 2024 | 5.48M | +46.7% |
| 2023 | 3.74M | +40.7% |
| 2022 | 2.66M | +142.9% |
| 2021 | 1.09M | -94.8% |
| 2020 | 21.19M | +0.8% |
| 2019 | 21.02M | +1719.6% |
| 2018 | 1.16M | — |